Central Garden & Pet(CENTA)

Search documents
Central Garden & Pet Partners with Cal Athletics to Champion Pet Welfare and Celebrate the Human–Animal Bond
Businesswire· 2025-10-08 12:47
WALNUT CREEK, Calif.--(BUSINESS WIRE)---- $CENT #CalAthletics--Central Garden & Pet Company (NASDAQ: CENT), (NASDAQ: CENTA), a leading company in the pet and garden industries, has partnered with Cal to promote pet welfare and celebrate the powerful bond between people and their pets. As part of the collaboration, Central's trusted brands, Nylabone® and Cadet® are now the official pet toys, chews and treats of Cal Athletics. Throughout the season, Central and Cal will spotlight pet adoptions and engage fans ...
Central Garden & Pet Breaks Below 200-Day Moving Average - Notable for CENTA
Nasdaq· 2025-09-12 22:49
In trading on Friday, shares of Central Garden & Pet Co (Symbol: CENTA) crossed below their 200 day moving average of $32.45, changing hands as low as $32.31 per share. Central Garden & Pet Co shares are currently trading off about 2.7% on the day. The chart below shows the one year performance of CENTA shares, versus its 200 day moving average:Looking at the chart above, CENTA's low point in its 52 week range is $27.70 per share, with $37.35 as the 52 week high point — that compares with a last trade of $ ...
Central Garden (CENTA) is an Incredible Growth Stock: 3 Reasons Why
ZACKS· 2025-09-08 22:11
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the task of finding cutting-edge growth stocks is made easy with the help of the Zacks Growth Sty ...
Central Garden & Pet(CENTA) - 2025 Q3 - Quarterly Report
2025-08-07 18:16
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 28, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Central Garden & Pet Company Delaware 001-33268 68-0275553 (Commission File Number) (I.R.S. Employer Identification No.) 1340 Treat Blvd., Suite 600, Walnut ...
Central Garden & Pet Company: No Sales Growth In Sight
Seeking Alpha· 2025-08-07 17:49
Core Insights - The article emphasizes the investment philosophy focused on small cap companies, highlighting the importance of identifying mispriced securities through understanding financial drivers and utilizing DCF model valuation [1] Group 1: Investment Philosophy - The investment approach is not confined to traditional categories such as value, dividend, or growth investing, but rather considers all prospects of a stock to assess risk-to-reward [1] Group 2: Market Focus - The investment strategy encompasses markets in the US, Canada, and Europe, indicating a broad geographical focus for potential investment opportunities [1]
Central Garden (CENTA) Q3 Earnings Beat Estimates
ZACKS· 2025-08-06 23:46
分组1 - Central Garden (CENTA) reported quarterly earnings of $1.56 per share, exceeding the Zacks Consensus Estimate of $1.34 per share, and showing an increase from $1.32 per share a year ago, resulting in an earnings surprise of +16.42% [1] - The company posted revenues of $960.91 million for the quarter ended June 2025, which was 2.66% below the Zacks Consensus Estimate and a decrease from $996.35 million year-over-year [2] - Central Garden has surpassed consensus EPS estimates in all four of the last quarters, but has only topped revenue estimates once in the same period [2] 分组2 - The stock has gained approximately 8.5% since the beginning of the year, outperforming the S&P 500's gain of 7.1% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to those expectations [4] - The current consensus EPS estimate for the upcoming quarter is -$0.07 on revenues of $667.47 million, and for the current fiscal year, it is $2.52 on revenues of $3.14 billion [7] 分组3 - The Zacks Industry Rank places the Consumer Products - Discretionary sector in the top 28% of over 250 Zacks industries, indicating a favorable outlook for stocks in this category [8] - Central Garden currently holds a Zacks Rank 1 (Strong Buy), suggesting that the shares are expected to outperform the market in the near future [6]
Central Garden (CENTA) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-07-30 15:01
The market expects Central Garden (CENTA) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on August 6, might help the stock move higher if these key numbers are bett ...
All You Need to Know About Central Garden (CENTA) Rating Upgrade to Strong Buy
ZACKS· 2025-07-17 17:01
Core Viewpoint - Central Garden (CENTA) has received an upgrade to a Zacks Rank 1 (Strong Buy), indicating a positive outlook based on rising earnings estimates, which are a significant factor influencing stock prices [1][4][6]. Earnings Estimates and Ratings - The Zacks rating system is based solely on a company's changing earnings picture, tracking the Zacks Consensus Estimate for EPS from sell-side analysts [2]. - The Zacks rating upgrade reflects an improvement in Central Garden's earnings outlook, which is expected to positively impact its stock price [4][6]. Impact of Earnings Estimates on Stock Prices - Changes in future earnings potential, as indicated by earnings estimate revisions, are strongly correlated with near-term stock price movements, influenced by institutional investors [5]. - For Central Garden, the increase in earnings estimates suggests an improvement in the company's underlying business, likely leading to higher stock prices as investors respond to this trend [6]. Zacks Rank System - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with Zacks Rank 1 stocks historically generating an average annual return of +25% since 1988 [8]. - Central Garden's upgrade to Zacks Rank 1 places it in the top 5% of Zacks-covered stocks, indicating a strong potential for market-beating returns in the near term [10][11]. Earnings Estimate Revisions for Central Garden - Central Garden is projected to earn $2.52 per share for the fiscal year ending September 2025, with no year-over-year change expected [9]. - Over the past three months, the Zacks Consensus Estimate for Central Garden has increased by 10.1%, reflecting analysts' growing confidence in the company's performance [9].
Central Garden & Pet(CENTA) - 2025 Q3 - Quarterly Results
2025-08-06 20:18
[Filing Information](index=1&type=section&id=Filing%20Information) This section provides essential identification and registration details for Central Garden & Pet Company and its listed securities [Registrant Information](index=1&type=section&id=Registrant%20Information) This section provides the core identification details of the registrant, Central Garden & Pet Company, including its incorporation jurisdiction, commission file number, and principal executive office address - **Registrant Name**: Central Garden & Pet Company[2](index=2&type=chunk) - **Incorporation Jurisdiction**: Delaware[2](index=2&type=chunk) - **Principal Executive Offices Address**: 1340 Treat Boulevard, Suite 600, Walnut Creek, California 94597[2](index=2&type=chunk) [Securities Information](index=1&type=section&id=Securities%20Information) This part details the classes of securities registered by the company pursuant to Section 12(b) of the Securities Exchange Act, specifying their trading symbols and the exchange where they are listed Registered Securities | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | :------------------ | :---------------- | :---------------------------------------- | | Common Stock | CENT | The NASDAQ Stock Market LLC | | Class A Common Stock| CENTA | The NASDAQ Stock Market LLC | [Item 2.02 Results of Operations and Financial Condition](index=3&type=section&id=Item%202.02%20Results%20of%20Operations%20and%20Financial%20Condition) This section reports an update to the company's financial outlook for the fiscal year ending September 28, 2025 [Fiscal Year Outlook Update](index=3&type=section&id=Fiscal%20Year%20Outlook%20Update) Central Garden & Pet Company announced an increase in its financial outlook for the fiscal year ending September 28, 2025, communicated via a press release issued on July 11, 2025 - **Central Garden & Pet Company** increased its outlook for the fiscal year ending September 28, 2025, via a press release on July 11, 2025[7](index=7&type=chunk) - The press release is attached as **Exhibit 99.1**[7](index=7&type=chunk) [Item 9.01 Financial Statements and Exhibits](index=3&type=section&id=Item%209.01%20Financial%20Statements%20and%20Exhibits) This section lists the financial statements and exhibits filed as part of the report, including the press release and interactive data file [Exhibits List](index=3&type=section&id=Exhibits%20List) This section provides a list of exhibits filed as part of this Form 8-K, including the press release detailing the updated financial outlook and the interactive data file Filed Exhibits | Exhibit Number | Description | | :------------- | :-------------------------------------------------------------- | | Exhibit 99.1 | Press release dated July 11, 2025 | | Exhibit 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | [Signatures](index=4&type=section&id=SIGNATURES) This section confirms the official signing of the report on behalf of Central Garden & Pet Company by its Chief Financial Officer, Nicholas Lahanas, on July 11, 2025 - The report was signed by **Nicholas Lahanas**, Chief Financial Officer of Central Garden & Pet Company[11](index=11&type=chunk) - The report was dated and signed on **July 11, 2025**[11](index=11&type=chunk)
Central Garden & Pet(CENTA) - 2025 Q2 - Quarterly Report
2025-05-08 17:21
PART I. FINANCIAL INFORMATION [Item 1. Financial Statements (Unaudited)](index=4&type=section&id=Item%201.%20Financial%20Statements%20%28Unaudited%29) This section presents the unaudited condensed consolidated financial statements, including balance sheets, statements of operations, comprehensive income, and cash flows, with detailed accounting policy notes Condensed Consolidated Balance Sheet Highlights (in thousands) | Account | March 29, 2025 | March 30, 2024 | September 28, 2024 | | :--- | :--- | :--- | :--- | | **Total current assets** | $1,975,253 | $1,850,618 | $1,886,806 | | Inventories, net | $824,281 | $914,352 | $757,943 | | **Total Assets** | **$3,629,617** | **$3,540,018** | **$3,553,439** | | **Total current liabilities** | $597,651 | $556,490 | $515,384 | | Long-term debt | $1,190,724 | $1,188,955 | $1,189,809 | | **Total Equity** | **$1,543,404** | **$1,512,167** | **$1,557,545** | Condensed Consolidated Statements of Operations Highlights (in thousands, except per share) | Metric | Three Months Ended Mar 29, 2025 | Three Months Ended Mar 30, 2024 | Six Months Ended Mar 29, 2025 | Six Months Ended Mar 30, 2024 | | :--- | :--- | :--- | :--- | :--- | | Net sales | $833,537 | $900,090 | $1,489,973 | $1,534,623 | | Gross profit | $273,083 | $278,880 | $468,782 | $457,725 | | Operating income | $93,324 | $93,447 | $121,316 | $101,859 | | Net income attributable to Central | $63,633 | $61,987 | $77,642 | $62,417 | | Diluted EPS | $0.98 | $0.93 | $1.19 | $0.93 | Condensed Consolidated Statements of Cash Flows Highlights (Six Months Ended, in thousands) | Cash Flow Activity | March 29, 2025 | March 30, 2024 | | :--- | :--- | :--- | | Net cash used by operating activities | $(115,695) | $(94,302) | | Net cash used in investing activities | $(20,203) | $(80,286) | | Net cash used by financing activities | $(99,724) | $(13,171) | | **Net decrease in cash** | **$(237,066)** | **$(187,344)** | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Detailed notes explain accounting policies, including the TDBBS acquisition, inventory and intangible asset breakdowns, $1.2 billion in long-term debt, segment performance, and an update on the Nite Glow legal contingency - On November 3, 2023, the Company acquired TDBBS, LLC, a provider of premium natural dog chews and treats, for approximately **$60 million**, resulting in **$23 million** in intangible assets and **$5 million** in goodwill[54](index=54&type=chunk) - The company has three series of senior notes outstanding, totaling **$1.2 billion** in principal: **$300 million** at 5.125% due 2028, **$500 million** at 4.125% due 2030, and **$400 million** at 4.125% due 2031[63](index=63&type=chunk) Segment Operating Income (Six Months Ended, in thousands) | Segment | March 29, 2025 | March 30, 2024 | | :--- | :--- | :--- | | Pet segment | $111,871 | $106,047 | | Garden segment | $61,154 | $48,180 | | Corporate | $(51,709) | $(52,368) | | **Total operating income** | **$121,316** | **$101,859** | - A legal dispute with Nite Glow regarding a patent, breach of contract, and misappropriation of confidential information is ongoing; a retrial on damages concluded in March 2024, with no decision issued, and the company believes the final resolution will not have a material impact[95](index=95&type=chunk) [Item 2. MD&A of Financial Condition and Results of Operations](index=20&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial results, noting a 7.4% Q2 FY2025 net sales decrease, improved gross margin, a 2.9% six-month net sales decrease, and a 19.1% operating income increase, alongside liquidity, capital resources, debt, and stock repurchase details [Results of Operations](index=21&type=section&id=Results%20of%20Operations) Q2 FY2025 net sales decreased **7.4%** to **$833.5 million** due to order timing and weather, while gross margin improved; six-month net sales decreased **2.9%** to **$1.49 billion**, but operating income rose **19.1%** to **$121.3 million** Q2 FY2025 vs Q2 FY2024 Performance (in millions) | Metric | Q2 FY2025 | Q2 FY2024 | Change (%) | | :--- | :--- | :--- | :--- | | Net Sales | $833.5 | $900.1 | -7.4% | | Gross Profit | $273.1 | $278.9 | -2.1% | | Operating Income | $93.3 | $93.4 | -0.1% | | Diluted EPS | $0.98 | $0.93 | +5.4% | - The Q2 sales decline was driven by the timing of customer orders shifting sales into Q1, continued weak demand for pet durables (outdoor cushions, pet beds, aquatics), and a delayed start to the garden season due to weather[106](index=106&type=chunk) Six Months FY2025 vs FY2024 Performance (in millions) | Metric | Six Months FY2025 | Six Months FY2024 | Change (%) | | :--- | :--- | :--- | :--- | | Net Sales | $1,490.0 | $1,535.0 | -2.9% | | Gross Profit | $468.8 | $457.7 | +2.4% | | Operating Income | $121.3 | $101.8 | +19.1% | | Diluted EPS | $1.19 | $0.93 | +28.0% | - In March 2025, the company decided to wind-down its U.K. operations, incurring **$5.3 million** in one-time costs during the quarter[103](index=103&type=chunk) [Use of Non-GAAP Financial Measures](index=24&type=section&id=Use%20of%20Non-GAAP%20Financial%20Measures) The company uses non-GAAP measures like adjusted EBITDA and non-GAAP net income, excluding one-time charges, with Q2 2025 non-GAAP net income at **$67.7 million** ($1.04 diluted EPS) and six-month non-GAAP net income at **$81.7 million** ($1.25 diluted EPS) GAAP to Non-GAAP Net Income Reconciliation (in thousands, except per share) | | Three Months Ended Mar 29, 2025 | Six Months Ended Mar 29, 2025 | | :--- | :--- | :--- | | GAAP net income | $63,633 | $77,642 | | Facility closures | $5,339 | $5,339 | | Tax effect | $(1,255) | $(1,255) | | **Non-GAAP net income** | **$67,717** | **$81,726** | | GAAP diluted EPS | $0.98 | $1.19 | | **Non-GAAP diluted EPS** | **$1.04** | **$1.25** | - Non-GAAP adjustments for Q2 2025 relate to a **$5.3 million** charge for winding down U.K. operations, while Q2 2024 adjustments related to a **$5.3 million** charge for closing a California facility and consolidating distribution[135](index=135&type=chunk) [Liquidity and Capital Resources](index=27&type=section&id=Liquidity%20and%20Capital%20Resources) Liquidity is managed through operations and a **$750 million** credit facility with **$706 million** available, as net cash used by operating activities increased to **$115.7 million**, and stock repurchases significantly rose to **$93.4 million**, while total debt remained stable at **$1.2 billion** - Net cash used by operating activities increased by **$21.4 million** year-over-year for the six-month period, primarily due to changes in working capital[147](index=147&type=chunk) - Cash used in financing activities increased to **$99.7 million** from **$13.2 million** year-over-year for the six-month period, driven by significant stock repurchases[149](index=149&type=chunk) - During the first six months of FY2025, the company repurchased approximately **2.1 million** shares of CENTA stock for **$63.2 million** and **0.9 million** shares of CENT stock for **$30.2 million**[149](index=149&type=chunk) - As of March 29, 2025, total debt was **$1,190.8 million**, and net availability under the Credit Facility was approximately **$706 million**[153](index=153&type=chunk)[165](index=165&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) No material changes in market risk exposure have occurred since the last Form 10-K filing - No material change in market risk exposure has occurred since the last Form 10-K filing[175](index=175&type=chunk) [Item 4. Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were effective as of March 29, 2025, with no material changes to internal control over financial reporting during the quarter - The Principal Executive Officer and Principal Financial Officer concluded that disclosure controls and procedures were effective as of the end of the period[176](index=176&type=chunk) - No changes in internal control over financial reporting occurred during the quarter that have materially affected, or are reasonably likely to materially affect, internal controls[177](index=177&type=chunk) PART II. OTHER INFORMATION [Item 1. Legal Proceedings](index=31&type=section&id=Item%201.%20Legal%20Proceedings) An update on the ongoing Nite Glow Industries litigation notes a retrial on damages concluded in March 2024 with a pending decision, and the company does not expect a material financial impact - The company is involved in a legal proceeding with Nite Glow Industries, initiated in 2012; a retrial on damages for a misappropriation claim concluded in March 2024, but no decision has been issued by the court[179](index=179&type=chunk) [Item 1A. Risk Factors](index=32&type=section&id=Item%201A.%20Risk%20Factors) No material changes to risk factors have been reported since the most recent Form 10-K filing - There have been no material changes to the risk factors disclosed in the most recent Form 10-K[182](index=182&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=32&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During the quarter ended March 29, 2025, the company repurchased **1,343,279** shares at an average price of **$33.38**, with approximately **$101.2 million** remaining for future repurchases Equity Repurchases for Quarter Ended March 29, 2025 | Period | Total Shares Purchased | Average Price Paid | Value Remaining for Purchase | | :--- | :--- | :--- | :--- | | Dec 29, 2024 - Feb 1, 2025 | 4,804 | $30.68 | $131,028,000 | | Feb 2, 2025 - Mar 1, 2025 | 181,824 | $32.62 | $131,028,000 | | Mar 2, 2025 - Mar 29, 2025 | 1,156,651 | $33.51 | $101,172,000 | | **Total** | **1,343,279** | **$33.38** | **$101,172,000** | - As of March 29, 2025, the company had **$101 million** of authorization remaining under its 2019 and 2024 Repurchase Authorizations[185](index=185&type=chunk) [Item 5. Other Information](index=32&type=section&id=Item%205.%20Other%20Information) No directors or officers adopted, modified, or terminated a Rule 10b5-1 or non-Rule 10b5-1 trading arrangement during the quarter ended March 29, 2025 - No directors or officers reported any adoption, modification, or termination of a Rule 10b5-1 trading arrangement during the quarter[185](index=185&type=chunk) [Item 6. Exhibits](index=33&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO and CFO certifications, guarantor subsidiaries, and Inline XBRL financial statements - Exhibits filed include CEO and CFO certifications (31.1, 31.2, 32.1, 32.2) and financial data in Inline XBRL format (101, 104)[186](index=186&type=chunk)